Their current libraries currently contain billions of peptides from thosuands of structural families...so in principle they could make libraries containing trillions of peptides and still own the libraries. They basically have control of this particular drug class. And they're constantly adding to their library - adding diversity, which means adding new genomes.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
0.000(0.00%) |
Mkt cap ! $839.8M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.45 | $1.42 | $3.475M | 2.414M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 55564 | $1.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 6099 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |